0
Article Tier 2 Detection Methods Human Health Effects Nanoplastics Reproductive & Development Sign in to save

Development of Microfluidic, Serum-Free Bronchial Epithelial Cells-on-a-Chip to Facilitate a More Realistic In vitro Testing of Nanoplastics

Frontiers in Toxicology 2021 16 citations

AI summary Read the abstract

A microfluidic bronchial epithelial cell-on-a-chip model was developed to test nanoplastic toxicity under dynamic flow conditions, with polystyrene nanoplastics found to reduce barrier integrity and trigger inflammatory signaling in a way not fully captured by conventional static cell culture systems.

Polymers
Study Type In vitro

Most cell culture models are static, but the cellular microenvironment in the body is dynamic. Here, we established a microfluidic-based in vitro model of human bronchial epithelial cells in which cells are stationary, but nutrient supply is dynamic, and we used this system to evaluate cellular uptake of nanoparticles. The cells were maintained in fetal calf serum-free and bovine pituitary extract-free cell culture medium. BEAS-2B, an immortalized, non-tumorigenic human cell line, was used as a model and the cells were grown in a chip within a microfluidic device and were briefly infused with amorphous silica (SiO2) nanoparticles or polystyrene (PS) nanoparticles of similar primary sizes but with different densities. For comparison, tests were also performed using static, multi-well cultures. Cellular uptake of the fluorescently labeled particles was investigated by flow cytometry and confocal microscopy. Exposure under dynamic culture conditions resulted in higher cellular uptake of the PS nanoparticles when compared to static conditions, while uptake of SiO2 nanoparticles was similar in both settings. The present study has shown that it is feasible to grow human lung cells under completely animal-free conditions using a microfluidic-based device, and we have also found that cellular uptake of PS nanoparticles aka nanoplastics is highly dependent on culture conditions. Hence, traditional cell cultures may not accurately reflect the uptake of low-density particles, potentially leading to an underestimation of their cellular impact.

More Papers Like This

Article Tier 2

An integrated microfluidic pulmonary alveolus system for gradient-controlled investigation of nanoplastic-triggered lung inflammation and injury dynamics

AI summary Read the abstract

Researchers developed an integrated lung-on-a-chip microfluidic system that generates precise concentration gradients of nanoparticles to study their effects on human alveolar barriers. They found that high-dose polystyrene nanoplastics caused clear toxicity to lung tissue models, while low doses triggered defensive inflammatory and antioxidant responses without significant damage. The platform offers a new tool for systematically evaluating dose-dependent respiratory risks from nanoplastic exposure.

Article Tier 2

Cytotoxicity analysis of polystyrene nanoplastics in the bronchial epithelial cell line BEAS-2B

AI summary Read the abstract

Researchers exposed bronchial epithelial cells to europium-doped polystyrene nanoplastics to assess cytotoxicity in a model of the human airway. The nanoplastics caused dose-dependent cell death and inflammatory signaling, supporting concerns about respiratory health effects from inhaled plastic particles.

Article Tier 2

Evaluation of the pulmonary toxicity of PSNPs using a Transwell-based normal human bronchial epithelial cell culture system

AI summary Read the abstract

Researchers used a Transwell air-liquid interface cell culture system to assess how polystyrene nanoplastics affect human bronchial epithelial cells, finding that even ultralow, non-cytotoxic doses triggered inflammatory signaling (NF-κB, NLRP3), while higher doses induced apoptosis and autophagy — suggesting nanoplastics pose a pulmonary health risk at ambient exposure levels.

Article Tier 2

Development of Apical-out Airway Organoids to Evaluate Respiratory Toxicity of Polystyrene Microplastics

AI summary Read the abstract

Researchers developed apical-out airway organoids as an in vitro model to evaluate the respiratory toxicity of polystyrene microplastics, finding that microplastic exposure induced inflammation and barrier disruption in a model that better represents human airway exposure than standard cell cultures.

Article Tier 2

Polystyrene nanoplastics impair epithelial barrier establishment and modulate extracellular vesicle release in human bronchial cells cultured at the air-liquid interface

AI summary Read the abstract

Scientists exposed lab-grown human airway cells to tiny nanoplastic particles (like those found in breathing air polluted with plastic waste) and found the particles weakened the protective barrier these cells normally form, while also triggering inflammation-related signals. This suggests nanoplastics could make airways more vulnerable, especially in people whose lung lining is already damaged or still developing—though this was shown in a lab model, not in humans breathing polluted air, so more research is needed to confirm real-world impact.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper